Travere Therapeutics to Report Second Quarter 2023 Financial Results
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter…
Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 20, 2023 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM;…
Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying pathological hallmarks of Alzheimer’s disease…
Regulated information — Inside information July 18, 2023, 9:20 PM ET July 19, 2023, 3:20 AM CET …
OCALA, Fla., July 18, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued…
DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the…
— Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources — — Maximizes…
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to biopharma customers // Launch of…
Eric Faulkner, currently Sr. Vice President, CMC, appointed as Chief Technical Officer NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) —…
Webinar to be held on Tuesday, July 25th, 2023 at 11:30 a.m. ETFOSTER CITY, Calif., July 18, 2023 (GLOBE NEWSWIRE)…